The next generation of anatomic pathology and cancer diagnostics
Learn how we do it
More objective data from a single tissue sample than ever before
Learn how we do it
Better data for improved cancer diagnosis and prognosis
Learn how we do it

Cernostics is focused on delivering the next generation of cancer diagnostics & prognostics through a unique approach to tissue analysis.

Learn about our approach...

Watch our video...

Barrett's Esophagus &
Esophageal Cancer

Three million people in the U.S. have Barrett’s Esophagus, a known precursor to esophageal cancer. Until now, identifying which patients are at greatest risk for esophageal cancer has been impossible. Cernostics is looking to change that… Learn how
View All News
Ground-breaking Cancer Diagnostic Technology Receives Phase 2 SBIR Grant... Read More
Cernostics Announces Three Patents Addressing the TissueCypher™ Technology Platform... Read More
Cernostics Collaborates with Prestigious Academic Medical Center in The Netherlands... Read More
10/18/2014 Vienna, Austria
UEG Week (United European Gastroenterology Week)
06/23/2014 San Diego, CA
BIO International Convention
05/03/2014 Chicago, IL
DDW (Digestive Disease Week)
01/13/2014 San Francisco, CA
JP Morgan Healthcare Conference
11/13/2013 Philadelphia, PA
PA BIO Life Sciences Future Meeting